Preferred Label : azilsartan medoxomil;
MeSH note : an azilsartan prodrug and angiotensin II type 1 receptor blocker;
CISMeF synonym : TAK 491;
MeSH hyponym : TAK491; TAK-491;
MeSH CAS label : 1H-benzimidazole-7-carboxylic acid, 1-((2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-,
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester;
Is substance : O;
UNII : LL0G25K7I2;
Origin ID : C557413;
UMLS CUI : C2698291;
ATC code(s)
Automatic exact mappings (from CISMeF team)
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-10-fra.php#a19
2016
false
false
false
Canada
French
azilsartan medoxomil and diuretics
drug combinations
chlorthalidone
azilsartan medoxomil
hyponatremia
pharmacovigilance note
benzimidazoles
oxadiazoles
---
https://www.ema.europa.eu/medicines/human/EPAR/Ipreziv
2012
false
United Kingdom
English
French
drug evaluation
package leaflet
summary of product characteristics
syndication feed
Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional
release oral tablet (clinical drug)
Product containing precisely azilsartan medoxomil 80 milligram/1 each conventional
release oral tablet (clinical drug)
Azilsartan medoxomil (product)
benzimidazoles
benzimidazoles
oxadiazoles
oxadiazoles
azilsartan medoxomil
azilsartan medoxomil
prodrugs
drug approval
treatment outcome
administration, oral
adult
hypertension
antihypertensive agents
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
azilsartan medoxomil
---
https://www.ema.europa.eu/medicines/human/EPAR/Edarbi
2012
false
United Kingdom
French
English
drug evaluation
summary of product characteristics
package leaflet
syndication feed
Product containing precisely azilsartan medoxomil 80 milligram/1 each conventional
release oral tablet (clinical drug)
Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional
release oral tablet (clinical drug)
Azilsartan medoxomil (product)
benzimidazoles
benzimidazoles
oxadiazoles
oxadiazoles
azilsartan medoxomil
azilsartan medoxomil
drug approval
treatment outcome
administration, oral
adult
hypertension
antihypertensive agents
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
drug interactions
pregnancy
breast feeding
prodrugs
drug evaluation, preclinical
azilsartan medoxomil
---
Summary Basis of Decision (SBD) for Edarbi
Azilsartan medoxomil, 40 mg and 80 mg, Tablet, Oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00045
2012
true
Canada
French
English
canada
drug evaluation
risk assessment
clinical trials as topic
drug information
Product containing precisely azilsartan medoxomil 40 milligram/1 each conventional
release oral tablet (clinical drug)
Product containing precisely azilsartan medoxomil 80 milligram/1 each conventional
release oral tablet (clinical drug)
benzimidazoles
benzimidazoles
oxadiazoles
oxadiazoles
azilsartan medoxomil
azilsartan medoxomil
drug approval
treatment outcome
administration, oral
adult
hypertension
antihypertensive agents
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
prodrugs
azilsartan medoxomil
---